Thermo Fisher's business strategy involves expansion through strategic acquisition of technologies and businesses that boost ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $598.61 which represents a decrease of $-2.31 or -0.38% from the prior close of $600.92. The stock opened at $602.63 and ...

The latest CorEvitas registry – the company’s 11th independent registry – will allow the prospective evaluation of adolescent AD patients to better understand the disease and the treatment pathway. It ...

THERMO FISHER SCIENTIFIC INC (TMO) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 69% based on the firm’s underlying fundamentals and ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $612.94 which represents a decrease of $-5.63 or -0.91% from the prior close of $618.57. The stock opened at $620 and touched ...

Thermo Fisher (TMO) stock slips as plant producing RSV treatment. Beyfortus developed by AstraZeneca (AZN), Sanofi (SNY) ...

Thermo Fisher Scientific TMO announced the launch of the international ... to positively boost the market sentiment toward the stock. Thermo Fisher currently has a market capitalization of $ ...

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements ...